Control of Resection Margins during Breast-Conserving and Oncoplastic Surgeries
pdf (Русский)

Keywords

breast cancer
breast-conserving surgery
resection margins
neoadjuvant systemic therapy

How to Cite

Krivorotko, P. V., Bondarchuk, Y. I., Komyahov , A. V., Bagnenko, S. S., Zhiltsova, E. K., Chernaya , A. V., Semiglazov, V. V., Artemyeva, A. S., Tabagua, T. T., Gigolaeva, L. P., Emelyanov, A. S., Amirov, N. S., Pesotsky, R. S., Mortada, V. V., Bekkeldieva, N. B., Yerechshenko, S. S., Zernov, K. Y., Nikolaev, K. S., Levchenko, V. E., Ulrikh, D. G., Enaldieva, D. A., Belyaev, A. M., & Semiglazov, V. F. (2024). Control of Resection Margins during Breast-Conserving and Oncoplastic Surgeries . Voprosy Onkologii, 70(1), 96–104. https://doi.org/10.37469/0507-3758-2024-70-1-96-104

Abstract

Introduction. Surgery is fundamental in complex treatment of breast cancer (BC). The main indicator of safety of the breast-conserving surgery (BCS) is a negative resection margin. The standard surgical practice is re-excision in case the resection margin contains cancer cells. However, the BCS goal is to preserve volume and shape of the breast and, if possible, to remove less surrounding tumor tissue, which is associated with a minimal risk of recurrence. Aim. To assess and analyze surgery performed during BCS and oncoplastic procedures for BC using a planned pathomorphological examination of the resection margins status.

Materials and Methods. 2,168 conservative surgeries were analyzed; patients were divided in two groups depending on the neoadjuvant systemic therapy (NST). The first group included 1,357 patients who didn’t receive NST before surgery; the second group included 811 patients who underwent NST. Subset analysis of the positive resection margin (R1) detection rate was carried out or without intraoperative resection margin on the X-ray device. After each BCS, resection margin status was assessed on planned histologic examination for the presence of the tumor cells, with subsequent analysis of the frequency of reoperations when R1 was found.

Results. In 2 168 tested surgical specimens after BCS, R1 was found in 111 (5.11 %) cases. From 1357 first group patients after BCS, R1 was found in 83 (6.11 %) cases; from 811 surgeries conducted in the second group R1 was found in 28 (3.45 %) cases. Reoperations were performed in 80 cases and tumor cells were found in 28 cases on follow-up pathomorphological examination. Intraoperative X-ray assessment was performed in 705 (32.5 %) patients; R1 was detected in 17 (2.4 %) cases, which reduced the number of reoperations.

Conclusion. Today the gold standard for accurate assessment of resection margins status remains postoperative morphological examination of resection margins. Unfortunately, this method cannot influence the intraoperative decision of a surgeon. Intraoperative X-ray examination of the resection margins can reduce the frequency of repeated surgical interventions due to timely detection.

https://doi.org/10.37469/0507-3758-2024-70-1-96-104
pdf (Русский)

References

Lei S., Zheng R., Zhang S., et al. Global patterns of breast cancer incidence and mortality: A popula-tion-based cancer registry data analysis from 2000 to 2020. Cancer Commun (London, England). 2021; 41(11): 1183-1194.-DOI: https://doi.org/10.1002/cac2.12207.

Fisher B., Jeong J.H., Anderson S., et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002; 347(8): 567-575.-DOI: https://doi.org/10.1056/NEJMoa020128.

Семиглазов В.Ф., Труфанова Е.C., Крживицкий П.И., и др. Клинико-биологическая модель для оценки эффективности системной терапии рака молочной железы. Вопросы онкологии. 2018; 64(3): 289-297.-DOI: https://doi.org/10.37469/0507-3758-2018-64-3-289-297. [Semiglazov V.F., Trufanova E.S., Krzhivitsky P.I., et al. Clinical and biological model for evaluation of the effec-tiveness of systemic therapy for breast cancer. Voprosy Onkologii = Problems in Oncology. 2018; 64(3): 289-297.-DOI: https://doi.org/10.37469/0507-3758-2018-64-3-289-297. (In Rus)].

Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast can-cer. N Engl J Med. 2002; 347(16): 1233-1241.-DOI: https://doi.org/10.1056/NEJMoa022152.

Wrubel E., Natwick R., Wright G.P. Breast-conserving therapy is associated with improved survival compared with mastectomy for early-stage breast cancer: a propensity score matched comparison us-ing the national cancer database. Ann Surg Oncol. 2021; 28(2): 914-919.-DOI: https://doi.org/10.1245/s10434-020-08829-4.

Nayyar A., Gallagher K.K., McGuire K.P. Definition and management of positive margins for inva-sive breast cancer. Surg Clin North Am. 2018; 98(4): 761-771.-DOI: https://doi.org/10.1016/j.suc.2018.03.008.

Семиглазов В.Ф., Семиглазов В.В., Николаев К.С., и др. Контроль хирургических краев ре-зекции при органосохраняющем лечении рака молочной железы. Онкохирургия. 2014; (1): 58-63-DOI: https://doi.org/10.37469/0507-3758-2018-64-3-289-297. [Semiglazov V.F., Semiglazov V.V., Nikolaev K.S., et al. Control of surgical resection margins in organ-sparing surgeries for breast cancer. Onkohirurgiya = Cancer Surgery. 2014; (1): 58-63-DOI: https://doi.org/10.37469/0507-3758-2018-64-3-289-297. (In Rus)].

Криворотько П.В., Бондарчук Я.И., Донских Р.В., и др. Контроль краев резекции после нео-адъювантной системной терапии при органосохраняющих операциях у больных раком мо-лочной железы. Вестник Северо-Западного государственного медицинского университета им. И.И. Мечникова. 2023; 15(1): 87-95.-DOI: https://doi.org/10.17816/mechnikov112609hnikov112609. [Krivorotko P.V., Bondarchuk Ya.I., Don-skikh R.V., et al. Control of resection margins after neoadjuvant systemic therapy in breast-conserving surgery in breast cancer patients. Herald of North-Western State Medical University named after I.I. Mechnikov. 2023; 15(1): 87-95.-DOI: https://doi.org/10.17816/mechnikov112609hnikov112609. (In Rus)].

Johns N., Dixon J.M. Should patients with early breast cancer still be offered the choice of breast conserving surgery or mastectomy? Eur J Surg Oncol. 2016; 42(11): 1636-1641.-DOI: https://doi.org/10.1016/j.ejso.2016.08.016.

Volders J.H., Negenborn V.L., Spronk P.E., et al. Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes. Breast Cancer Res Treat. 2018; 168(1): 1-12.-DOI:https://doi.org/10.1007/s10549-017-4598-5.

Margenthaler J.A., Dietz J.R., Chatterjee A. The Landmark series: breast conservation trials (includ-ing oncoplastic breast surgery). Ann Surg Oncol. 2021; 28(4): 2120-2127.-DOI: https://doi.org/10.1245/s10434-020-09534-y.

André C., Holsti C., Svenner A., et al. Recurrence and survival after standard versus oncoplastic breast-conserving surgery for breast cancer. BJS Open. 2021; 5(1): 13.-DOI: https://doi.org/10.1093/bjsopen/zraa013.

Moran M.S., Schnitt S.J., Giuliano A.E., et al. Society of Surgical Oncology–American Society for Radiation Oncology Consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages i and ii invasive breast cancer. J Clin Oncol. 2014; 32(14): 1507-15.-DOI: http://dx.doi.org/10.1200/jco.2013.53.3935.

Morrow M., Van Zee K.J., Solin L.J., et al. Society of Surgical Oncology-American Society for Radi-ation Oncology-American Society of Clinical Oncology Consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. Pract Radiat Oncol. 2016; 6(5): 287-295.-DOI: https://doi.org/10.1016/j.prro.2016.06.011.

Rubio I.T., Ahmed M., Kovacs T., Marco V. Margins in breast conserving surgery: A practice-changing process. Eur J Surg Oncol (EJSO). 2016; 42(5): 631-40.-DOI: http://dx.doi.org/10.1016/j.ejso.2016.01.019.

Vos E.L., Gaal J., Verhoef C., et al. Focally positive margins in breast conserving surgery: Predictors, residual disease, and local recurrence. Eur J Surg Oncol (EJSO). 2017; 43(10): 1846-54.-DOI: http://dx.doi.org/10.1016/j.ejso.2017.06.007.

Lin C., Wang K.Y., Chen H.L., et al. Specimen mammography for intraoperative margin assessment in breast conserving surgery: a meta-analysis. Scientific Reports. 2022; 12(1): 18440.-DOI: https://doi.org/10.1038/s41598-022-23234-5.

Бондарчук Я. И., Жильцова Е.К., Криворотько П.В., и др. Интраоперационная оценка краев резекции с использованием цифровой двухпозиционной секторографии (Faxitron PathVision). Опухоли женской репродуктивной системы. 2022; 18(4): 43-51.-DOI: https://doi.org/10.17650/1994-4098-2022-18-4-43-51. [Bondarchuk Y.I., Zhiltsova E.K., Krivorotko P.V., et al. Intraoperative evaluation of the resection margin with the usage of digital two-point sec-torography (Faxitron PathVision). Opukholi zhenskoy reproduktivnoy systemy = Tumors of Female Reproductive System. 2022; 18(4): 43-51.-DOI: https://doi.org/10.17650/1994-4098-2022-18-4-43-51. (In Rus)].

Бондарчук Я.И., Багненко С.С., Чёрная А.В., et al. Интраоперационная маммография образцов для оценки краев резекции при органосохраняющих операциях у больных раком молочной железы. Радиология — практика. 2023; (4): 71-81.-DOI: https://doi.org/10.52560/2713-0118-2023-4-71-81. [Bondarchuk Ya.I., Bagnenko S.S., Chernaya A.V., et al. Assessment of the status of resection margins in patients with breast cancer during breast-conserving surgery using intraoperative mammography. Radiology – Practice. 2023; 4: 71-81.-DOI: https://doi.org/10.52560/2713-0118-2023-4-71-81. (In Rus)].

Magnoni F., Corso G., Maisonneuve P., et al. A propensity score-matched analysis of breast-conserving surgery plus whole-breast irradiation versus mastectomy in breast cancer. J Cancer Res Clin Oncol. 2022; 149(3): 1085-93.-DOI: http://dx.doi.org/10.1007/s00432-022-03973-8.

Lombardi A., Pastore E., Maggi S., et al. Positive margins (R1) risk factors in breast cancer conserva-tive surgery. Breast Cancer (Dove Medical Press). 2019; 11: 243-248.-DOI: https://doi.org/10.2147/BCTT.S210788.

Lee J.H., Lee H., Bang Y.J., et al. Comparison of recurrence rate between re-excision with radiother-apy and radiotherapy-only groups in surgical margin involvement of in situ carcinoma. J Breast Can-cer. 2022; 25(4): 288-295.-DOI: https://doi.org/10.4048/jbc.2022.25.e36.

Рассказова Е.А., Зикиряходжаев А.Д., Волченко Н.Н., и др. Края резекции R1 после органо-сохраняющих/онкопластических операций у больных раком молочной железы. Опухоли жен-ской репродуктивной системы. 2021; 17(1): 12-19.-DOI: https://doi.org/10.17650/1994-4098-2021-17-1-12-19. [Rasskazova E.A., Zikiryakhodzhaev A.D., Volchenko N.N., et al. R1 resection margin after organ-sparing/oncoplastic surgeries for breast cancer. Tumors of Female Reproductive System. 2021; 17(1): 12-19.-DOI: https://doi.org/10.17650/1994-4098-2021-17-1-12-19. (In Rus)].

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2024